Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.22.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses    
Research and development $ 2,931,437 $ 1,944,411
General and administrative 4,916,277 4,344,602
Total operating expenses 7,847,714 6,289,013
Operating loss (7,847,714) (6,289,013)
Other expense (income)    
Change in fair value of derivative liabilities 21,165 (436,270)
Gain on forgiveness of PPP loan (117,953) 0
Interest expense 769,159 706,385
Interest income (3) (29)
Total other expense (income), net 672,368 270,086
Loss before income taxes (8,520,082) (6,559,099)
Provision for income taxes 2,100 1,600
Net loss and comprehensive loss $ (8,522,182) $ (6,560,699)
Loss per common share:    
Basic (in dollars per share) $ (0.02) $ (0.03)
Diluted (in dollars per share) $ (0.02) $ (0.03)
Weighted average shares of common stock outstanding used to compute loss per share:    
Basic (in shares) 406,599,390 230,746,878
Diluted (in shares) 406,599,390 231,420,973